BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krzywińska O, Bracha M, Jeanniere C, Recchia E, Kędziora Kornatowska K, Kozakiewicz M. Meta-Analysis of the Potential Role of miRNA-21 in Cardiovascular System Function Monitoring. Biomed Res Int 2020;2020:4525410. [PMID: 32337248 DOI: 10.1155/2020/4525410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sothivelr V, Hasan MY, Mohd Saffian S, Zainalabidin S, Ugusman A, Mahadi MK. Revisiting miRNA-21 as a Therapeutic Strategy for Myocardial Infarction: A Systematic Review. J Cardiovasc Pharmacol 2022;80:393-406. [PMID: 35767710 DOI: 10.1097/FJC.0000000000001305] [Reference Citation Analysis]
2 Scisciola L, Benedetti R, Chianese U, Anna Fontanella R, Del Gaudio N, Marfella R, Surina, Altucci L, Barbieri M, Paolisso G. The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: evidence in human cardiomyocyte cell line. Diabetes Res Clin Pract 2022;:110066. [PMID: 36058441 DOI: 10.1016/j.diabres.2022.110066] [Reference Citation Analysis]
3 Akhtarkhavari T, Bahrami AR, M Matin M. Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer. Eur J Pharmacol 2022;:175233. [PMID: 36038011 DOI: 10.1016/j.ejphar.2022.175233] [Reference Citation Analysis]
4 Chang WT, Shih JY, Lin YW, Huang TL, Chen ZC, Chen CL, Chu JS, Liu PY. miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts. Aging (Albany NY) 2022;14. [PMID: 35907209 DOI: 10.18632/aging.204194] [Reference Citation Analysis]
5 Tanase DM, Gosav EM, Petrov D, Teodorescu D, Buliga-finis ON, Ouatu A, Tudorancea I, Rezus E, Rezus C. MicroRNAs (miRNAs) in Cardiovascular Complications of Rheumatoid Arthritis (RA): What Is New? IJMS 2022;23:5254. [DOI: 10.3390/ijms23095254] [Reference Citation Analysis]
6 Speranza G, Mele GR, Favia P, Pederzolli C, Potrich C. Tuning Surface Properties via Plasma Treatments for the Improved Capture of MicroRNA Biomarkers. Materials 2022;15:2641. [DOI: 10.3390/ma15072641] [Reference Citation Analysis]
7 Wu C, Liu B, Wang R, Li G. The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years. Front Cardiovasc Med 2022;8:809580. [DOI: 10.3389/fcvm.2021.809580] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Surina S, Fontanella RA, Scisciola L, Marfella R, Paolisso G, Barbieri M. miR-21 in Human Cardiomyopathies. Front Cardiovasc Med 2021;8:767064. [PMID: 34778418 DOI: 10.3389/fcvm.2021.767064] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
9 Mrowicka M, Mrowicki J, Kucharska E, Smigielska B, Szaflik JP, Szaflik J, Majsterek I. The Role of Oxidative Stress and the Importance of miRNAs as Potential Biomarkers in the Development of Age-Related Macular Degeneration. Processes 2021;9:1328. [DOI: 10.3390/pr9081328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dai H, Wang J, Shi Z, Ji X, Huang Y, Zhou R. Predictive value of miRNA-21 on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24966. [PMID: 33725861 DOI: 10.1097/MD.0000000000024966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]